FREE DAILY STOCK MARKET NEWS

FREE DAILY STOCK MARKET NEWS

Health House opens the door for the doctors

10 January 2022
ASX: HHI
Jack Baker
Medical Marijuana Buds on Black Background

Health House International will provide training courses for alternative medicine treatments after securing a deal with Germany’s North-Rhine Association of General Practitioners.  

Most commonly the first port of call for accessing healthcare in Germany, GPs are a significant touchpoint for increasing the understanding and confidence in prescriptions of alternative medicines.  

Through its subsidiary CanPharma and group company Kalapa Germany, Health House will increase the knowledge base of the over 2500 doctors represented by the organisation as its first alternative medicine collaboration.  

The companies said they were all eager to share the knowledge gained through their research and efforts.  

“The well-being of the patient has the highest priority which is why we provide patients high-quality; moreover, we feel that this is also achieved by educating healthcare professionals with a solid foundation of knowledge on which to base their future prescriptions of medicinal cannabis,” CanPharma chief executive and Health House executive director Henrik Sprengel said.  

“Many doctors in Germany lack experience in using cannabinoids, which is why a broad training is so important. Kalapa is very happy to provide this support so that doctors feel safe in their treatment and educate themselves on the topic of cannabinoids,” Kalapa Germany managing director Gesa Riedewald said.    

“We are very pleased that we can share the medical know-how that we have acquired over many years at Kalapa Clinic with the General Practitioners’ Association.  

“It has always been our goal to work together with doctors to obtain the best possible and safest therapy for the patients,” Health House chief executive David Attwood said. 

HHI’s Australian Stock Exchange-listed price is trading at 8.3c (8:28 am UTC+8 hours) 

COMPANY OVERVIEW

Health House International Limited (formerly VPCL Limited) is an ASX listed international distributor of medicinal cannabis and was founded to pursue opportunities in the burgeoning global medicinal cannabis market, which in March 2021 completed a reverse takeover after successfully raising $3.5 million under a public offer. Since 2014, the Board and founding shareholders of the Company have been pioneers in the medicinal cannabis sector establishing a number of publicly-listed companies including AusCann Group, Zelira Therapeutics and CannPal Animal Therapeutics.

COMPANY INFORMATION

ASX: HHI

Website

https://healthhouse.com.au/
https://www2.asx.com.au/markets/company/hhi

FREE DAILY STOCK MARKET NEWS

Join our mailing list to receive the latest stock market news.

You have Successfully Subscribed!